Funded Local Who is raising money in your own backyard?

Vancouver, BC, June 14, 2006--Westport Innovations Inc. (TSX:WPT.TO), a global leader in gaseous-fuelled power technologies, today announced that it has entered into an agreement with Matco Capital Ltd. ("Matco") to reorganize Westport Research Inc. ("WRI"), a wholly-owned subsidiary of Westport, as part of Westport's shareholder value program.

VANCOUVER, BC – Westport Innovations Inc. (TSX:WPT), a global leader in gaseous-fuelled power technologies, today announced that one or more investment funds managed by Perseus, L.L.C., a U.S.-based private equity fund management company, have completed definitive agreements for a strategic investment of approximately $22.1 million in Westport to be completed in two separate tranches. The closing of the first tranche of $13.8 million is committed and will be funded on or before July 15, 2006.

Vancouver, May 24, 2006 - Zeugma Systems Inc., a venture-backed company developing a telecommunications system for next generation, high speed broadband networks, today announced completion of a US$13.5 million financing.

Vancouver, BC, March 16, 2006--(T-Net)--Response Biomedical Corp. (TSX-V: RBM), announced today that it has accepted a proposal received from potential new investors. The proposal requires the Company to arrange a brokered private placement for aggregate gross proceeds of $10 million and to undertake a restructuring of its Board.

Vancouver, BC, March 14, 2006--Forbes Medi-Tech Inc. (TSX:FMI; NASDAQ:FMTI) today announced the completion of the sale of its interest in Phyto-Source, the Company's 50-50 sterol manufacturing joint venture, for US$25 million to Chusei Oil Co. Ltd., the Japanese parent company of the Company's former joint venture partner, Chusei (U.S.A.) Inc. Forbes has received the US$25 million under the agreement, announced February 23, 2006. Forbes has also received the remaining US$1 million of its original US$4 million loan to Phyto-Source.

August 26, 2005-Genome Canada is pouring $17.5 million over three years into two cutting edge projects involving Simon Fraser University scientists. Other investors, including Genome BC, will match the funding, bringing the collective value of these projects-the Consortium for Genomics Research on All Salmonids Project (cGRASP) and The Pathogenomics of Innate Immunity (PI2)-to $32.3 million. The projects are among 33 recently funded by Genome Canada, a federally supported agency that invests in genomics and proteomics research nationally.

Sonus Pharmaceuticals (OncoGenex) Raises $17.8 Million in Private Placement of Common Stock

Funds will be used for clinical trials and to accelerate preclinical development programs